Daily non-political popular news in brief.
Zanzibar study paves way for mass co-delivery of three antiparasitic drugs
01-22-2008 · EurekAlert!Findings from a new study in Zanzibar, published Jan. 23 in PLoS Neglected Tropical Diseases, pave the way for the World Health Organization to recommend the mass co-delivery of three antiparasitic drugs for the first time. The study shows the safety of delivering three drugs simultaneously -- ivermectin, albendazole and praziquantel -- in order to tackle three diseases, elephantiasis, soil-transmitted worms, and schistosomiasis.
Read more »
Keywords: zanzibar, study, paves, way, mass, co-delivery, antiparasitic, drugs, pave, delivery, drug
« Previous | Next »
Similar news on "Zanzibar study paves way for mass co-delivery of three antiparasitic drugs":
- Zanzibar study paves way for mass co-delivery of 3 antiparasitic drugs
01-22-2008 · EurekAlert!
Findings from a new study in Zanzibar, published Jan. 23 in PLoS Neglected Tropical Diseases, pave the way for the World Health Organization to recommend the mass co-delivery of three antiparasitic drugs for the first time. The study shows the safety of delivering three drugs simultaneously -- ivermectin, albendazole and praziquantel -- in order to tackle three diseases, elephantiasis, soil-transmitted worms, and schistosomiasis.
Similar news · Read more »
- Mass drug treatment for elephantiasis is affordable compared with other public health programs
10-30-2007 · EurekAlert!
Once-yearly administration of two antiparasitic drugs to control lymphatic filariasis (elephantiasis) costs just $0.06 to $2.23 per person treated, making it comparatively inexpensive, according to a major new international study of treatment costs.
Similar news · Read more »
- Penn researchers show how nanocylinders deliver medicine better than nanospheres
04-05-2007 · EurekAlert!
Researchers at the University of Pennsylvania School of Medicine have discovered a better way to deliver drugs to tumors. By using a cylindrical-shaped carrier they were able sustain delivery of the anticancer drug paclitaxel to an animal model of lung cancer ten times longer than that delivered on spherical-shaped carriers. These findings have implications for drug delivery as well as for better understanding cylinder-shaped viruses like Ebola and H5N1 influenza.
Similar news · Read more »
- Porous structures help boost integration of host tissue with implants, study finds
01-30-2008 · EurekAlert!
Results published today in FASEB by researchers at Columbia University, including Jeremy Mao of the Columbia College of Dental Medicine, demonstrate a novel way of using porous structures as a drug-delivery vehicle that can help boost the integration of host tissue with surgically implanted titanium.
Similar news · Read more »
- Does a component of niacin point the way to anti-aging drugs?
02-08-2007 · EurekAlert!
In recent years, scientists have discovered that a family of enzymes called sirtuins can dramatically extend life in organisms as diverse as yeast, worms and flies. A number of scientific groups and biotechnology companies are eagerly searching for drug candidates able to boost sirtuin activity, hoping to develop an "anti-aging" drug. Now, a new study from scientists at the Wistar Institute points to another strategy for activating sirtuins to unleash their anti-aging powers.
Similar news · Read more »
- Discovery of an HIV inhibitor in human blood points to new drug class
04-19-2007 · EurekAlert!
A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
Similar news · Read more »
- Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
06-27-2007 · EurekAlert!
Polymeric nanoparticles are excellent carriers for delivering drugs. However, they are quickly removed from the blood, sometimes in minutes, rendering them ineffective in delivering drugs. This study reports that nanoparticles can be forced to remain in circulation by attaching to red blood cells. Prolonged circulation of nanoparticles in the blood may potentially open new opportunities for the treatment of conditions such as cancer and heart disease.
Similar news · Read more »
- Study suggests newer breast cancer drug may protect heart
06-08-2007 · EurekAlert!
By uncovering how one breast cancer drug protects the heart and another does not, Duke University Medical Center researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
Similar news · Read more »
- Nanoengineers mine tiny diamonds for drug delivery
10-12-2007 · EurekAlert!
Northwestern University researchers have shown that nanodiamonds are very effective at delivering chemotherapy drugs to cells without the negative effects associated with current drug delivery agents. Their study is the first to demonstrate the use of nanodiamonds, a new class of nanomaterials, in biomedicine. In addition to delivering cancer drugs, the model could be used for other applications, such as fighting tuberculosis or viral infections, say the researchers.
Similar news · Read more »
- Study paves way for development of macular degeneration cures
01-30-2008 · EurekAlert!
A new study of age-related macular degeneration, the disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
Similar news · Read more »
